Fin Trust Capital Advisors, LLC Guardant Health, Inc. Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 12 shares of GH stock, worth $421. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 12
-0.0%
Holding current value
$421
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding GH
# of Institutions
324Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Vanguard Group Inc Valley Forge, PA11.7MShares$411 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$394 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$355 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$243 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$211 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.59B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...